Select Language:
Researchers have uncovered a previously unknown genetic disorder that manifests as signs of premature aging alongside significant neurological issues. This breakthrough, led by scientists at Sanford Burnham Prebys Medical Discovery Institute in collaboration with international partners, offers new insights into how specific genetic mutations can impact both bodily functions and brain health.
The discovery originated when medical professionals examined a family where several teenagers displayed unusual symptoms. These young individuals exhibited prematurely greying hair and other features characteristic of rare progeria syndromes, conditions associated with accelerated aging. However, unlike typical progeria cases, they also experienced worsening motor skills, cognitive challenges, and neurological deterioration, indicating a different, previously unrecognized disorder.
To pinpoint the cause, scientists employed advanced genome sequencing techniques, which revealed a mutation in the IVNS1ABP gene. This gene had not been previously linked to aging or neurological diseases, making the finding particularly unexpected. To understand how this mutation influences human biology, researchers reprogrammed skin cells from the affected individuals into stem-like cells and guided them to develop into early-stage brain cells.
Microscopic examination revealed stark differences in these cells: they grew much more slowly and showed signs of entering cellular senescence—a state where cells cease dividing and functioning properly, often due to DNA damage. Further testing confirmed extensive genetic damage and elevated levels of aging-related molecules in these cells. The team discovered that the damage accumulated during cell division, which was disrupted by the mutation.
The mutation affects actin, a vital protein responsible for maintaining cell structure and facilitating division. In the affected cells, actin was misshapen and unstable, impairing the formation of a critical ring that ensures proper cell separation. This instability caused uneven cell division and excessive cellular stress, leading to cell death or dysfunction. These cellular anomalies could be the root causes of both the early aging signs and neurological deficits observed in patients.
Importantly, scientists managed to partially reverse these cellular issues in the lab by applying chemicals that stabilize actin filaments. Restoring actin stability improved the cells’ ability to divide normally, hinting at potential therapeutic approaches down the line.
This research underscores the effectiveness of combining genetic analysis with cutting-edge cell reprogramming methodologies to identify rare diseases and decode their underlying mechanisms. Future studies include testing potential treatments in animal models to assess their feasibility.
In summary, this discovery not only identifies a novel genetic disorder but also enhances our understanding of cellular aging and function. It paves the way for targeted therapies for affected individuals and broadens our knowledge of the aging process itself.





